To examine the impact of tumor-derived IL-17A in tumor microenvironment, tumor growth, and anti-tumor immunity development, a replication-deficient adenovirus expressing an IL-17A transgene (AdIL-17A) or an empty viral vector (Addl) were used to transduce murine 4T1 TNBC cells. Here, IL17A is linked to neoplasm.